Written and maintained by CASRAI Editorial Board
Last updated
This page describes products and general use; it is not medical advice.
What a silver wound care dressing is
A silver wound care dressing is a sterile dressing that contains a silver compound and is marketed as antimicrobial. FDA’s clearance record for one such product lists its common name simply as “Antimicrobial dressing” (FDA 510(k) K191819). Related searches such as “silver dressing for wound care” and “silver in wound care dressings” all describe this same product class.
For the plain, non-silver version of the category, see what a wound dressing is.
How silver dressings are built
A silver dressing is a carrier plus silver. The carrier is a conventional dressing material and the silver is added to it. Two FDA records show what that means in practice:
- Foam carrier. The cleared Ag Foam Dressing in K191819 is described as sterile and single-use, with silver compounds (0.25-0.35 mg/cm2) within a polyurethane foam layer. It absorbs wound fluid and, per the submission, releases silver ions in the presence of wound fluid to help reduce bacterial colonization within the dressing. That loading figure belongs to this one product; it is not a class norm.
- Foam adhesive and non-adhesive. The 510(k) summary K032742 (Advanced Medical Solutions, prepared 4 August 2004) describes “Silver Foam Adhesive and Non-Adhesive Wound Dressings” as sterile, extremely absorbent, conformable and semi-permeable to moisture vapour, helping maintain a moist environment.
Types of silver dressings
Carriers differ, and so do the indications each manufacturer’s clearance states. The table lists only types for which a record was read.
| Type (carrier) | Stated indication in the cited record | Key difference |
|---|---|---|
| Silver foam (K032742, 2004) | Moderately to heavily exuding, partial to full thickness wounds, including pressure ulcers, leg ulcers, diabetic foot ulcers, graft wounds and donor sites, skin tears, first and second-degree burns, surgical wounds, lacerations and abrasions | Absorbent foam, adhesive and non-adhesive forms |
| Silver foam (K191819, 2020) | Management of moderately to highly exuding wounds, including leg, foot and pressure ulcers, diabetic foot ulcers, abrasions, surgical wounds, donor sites and superficial or partial-thickness burns | Silver compounds within a polyurethane foam layer; available in adhesive, non-adhesive, silicone and bordered forms |
| Silver Hydrofiber (AQUACEL Ag+ line) | See the manufacturer-sourced table in our AQUACEL guide | Hydrofiber carrier; the Ag+ variants are impregnated with 1.2% ionic silver, per Convatec |
Indications are the manufacturers’ stated uses in their regulatory submissions, not a recommendation for any patient.
How FDA regulates silver dressings
The 2020 foam clearance K191819 carries product code FRO, “Dressing, Wound, Drug”, a General and Plastic Surgery panel code, with the classification shown as Unclassified (decision 14 May 2020, substantially equivalent). The 2004 summary K032742 cites “Dressing, wound and burn occlusive (21 CFR 878.4020)” as its classification line. In practice this means these dressings reach the US market through premarket notification (510(k)) by showing substantial equivalence to a predicate: K032742 named K022416 (Contreet Foam Dressing) and K191819 named K100218 (Biatain Ag Foam Dressing) and K120828 (Biatain Silicone Ag Foam Dressings). A 510(k) clearance is not a statement that the dressing outperforms others.
What the evidence says
Label language and trial evidence are different things. A Cochrane review, “Topical silver for treating infected wounds” (Vermeulen et al., CD005486, Issue 1, 24 January 2007), found three randomised trials with 847 participants and short follow-up. Its conclusion: “There is insufficient evidence to recommend the use of silver-containing dressings or topical agents for treatment of infected or contaminated chronic wounds.” That review is dated and covers infected or contaminated chronic wounds specifically, so treat it as one dated data point, not the current state of all evidence.
Safe use and handling basics
- Use the product exactly as its instructions for use (IFU) describe, including wear time, secondary dressing needs and contraindications; these vary by product.
- The K191819 submission describes that dressing as sterile and single-use; follow each product’s IFU on reuse and storage.
- Choice of dressing for a particular wound is a clinician’s decision.
Common mistakes
- Treating one product’s silver loading (such as 0.25-0.35 mg/cm2) as typical of all silver dressings.
- Reading an FDA clearance as proof of better healing. Clearance rests on substantial equivalence to a predicate.
- Assuming every product in a brand line contains silver; in the AQUACEL line the silver is a feature of the Ag+ variants only.
Frequently asked questions
What is a silver dressing for wound care?
It is a sterile dressing, for example a foam or a Hydrofiber, containing a silver compound and marketed as antimicrobial. The foam dressing in FDA 510(k) K191819 sits under product code FRO.
How is silver in wound care dressings used?
Per the foam submissions, silver ions are released when the dressing contacts wound fluid, to help reduce bacterial colonization within the dressing. Clinical use follows the product IFU and a clinician’s decision.
Is a silver dressing the same as an iodine dressing?
No. They use different antimicrobial agents. See iodine dressings for the iodine version.
Related reading
Our wound care clinic supply checklist covers the wider kit, and non-adherent dressings and hydrocolloid dressings are neighbouring categories. Dressing categories are also listed under wound dressings.
Sources
All sources checked 2026-10-30.
- FDA 510(k) summary K032742, Advanced Medical Solutions Ltd: https://www.accessdata.fda.gov/cdrh_docs/pdf3/K032742.pdf
- FDA 510(k) K191819, Winner Medical Co., Ltd., Ag Foam Dressing, decision 14 May 2020 (transcription of FDA data): https://fda.innolitics.com/device/K191819
- Vermeulen H et al., Topical silver for treating infected wounds, Cochrane Database of Systematic Reviews CD005486, 2007: https://www.cochrane.org/evidence/CD005486_topical-silver-treating-infected-wounds
- Convatec AQUACEL Ag+ information as summarised in /guides/what-is-aquacel
